Question 1

What are the differences between the two vision testing methods being compared?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients clinical trial (NCT00902109). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the results of this trial affect my current treatment for glaucoma?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients clinical trial (NCT00902109). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the risks or discomforts associated with the new testing method?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients clinical trial (NCT00902109). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for testing if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients clinical trial (NCT00902109). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific requirements I need to meet to qualify for this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients clinical trial (NCT00902109). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients clinical trial (NCT00902109). Contact the study team or your healthcare provider for specific answers.

What this study is about